Psma-pet/ct-guided salvage radiotherapy in recurrent or persistent prostate cancer and psa < 0.2 ng/ml

HIGHLIGHTS

• who: Nantia Solomonidou from the (UNIVERSITY) have published the article: PSMA-PET/CT-guided salvage radiotherapy in recurrent or persistent prostate cancer and PSAu2009 0.1 ng/ml and two consecutive rises. PSMA-PET/CT is not routinely used for staging patients with BR at low PSA serum levels ( and amp;lt; 0.2 ng/ ml). Regarding the discrepancy between low PSMA-PET/CT detection levels and favorable sRT results, there is no consensus, at present, about the role of PSMA-PET/CT imaging in patients with BR and PSA levels and amp;lt; 0.2 ng . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.